Sign in

CIK 0001540159

  • Non-accelerated filer
  • Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 905-475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4/A Grant or award Director acquired 140,625 shares (grant or award)
  10. 4/A Grant or award President acquired 1,827 shares (grant or award)
  11. 4/A Grant or award Director acquired 2,436 shares (grant or award)
  12. 4/A Grant or award Director acquired 8,524 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 9,255 shares (grant or award)
  14. 4 Grant or award Director acquired 1,218 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 1,218 shares (grant or award)
  16. 4 Grant or award Director acquired 2,436 shares (grant or award)
  17. 4 Open-market buy Director bought 140,625 shares at $3.20 ($450,000)
  18. 4 Open-market buy Director bought 2,436 shares at $4.11 ($10,012)
  19. 4 Open-market buy Director bought 8,524 shares at $4.11 ($35,034)
  20. 4 Open-market buy President bought 1,827 shares at $4.11 ($7,509)

Page 9 of 14 · 261 filings